Mega Lifesciences filed an opposition concerning its trademarks EUGICA and EUGICA HERBAL INFUSION—which refer to nutritional supplements and herbal remedies—, registered in class 5 (pharmaceutical products), against the client’s trademark EUGIA—related to an injectable drug. Neolpharma, in turn, filed an opposition based on its trademark ZEUGIAL —a medication for the treatment of neuropathic disease.
Eugia is a pharmaceutical company based in India, specializing in the provision of affordable and accessible specialized products, including General Injectables, Oncology, Ophthalmics, Hormonal products, and more. The company has a global presence, serving various regions around the world.
The Peruvian Trademark Office issued resolutions determining that both Mega Lifesciences’ and Neolpharma’s opposition are unfounded. Neolpharma Perú appealed and the procedure is pending.
